| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-11 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.49 | 0.001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.004 |